Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/19 → 1/1/22 |
Funding
- Bayer: $358,000.00
Phase II study of Regorafenib for Bevacizumab refractory Glioblastoma
- Ahluwalia, Manmeet (PI)
Project: Research project
Project: Research project
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/19 → 1/1/22 |